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D. J. Hunter*
Division of Research, New England Baptist Hospital, 125 Parker Hill Ave, Boston, MA 02120, United StatesExtensive efforts are currently underway to understand the
earliest pathologic changes in synovial joint tissues. These
efforts are motivated in part by a desire to understand the
pathophysiologic alterations that occur in diseases of the
joint. However, in large part the efforts are promoted by
the necessity to develop agents to modify structural changes
that occur with disease, and the parallel requirement that
we have imaging methods to measure these structural
changes that are valid, responsive and clinically relevant.
Historically we have relied upon plain radiography to depict
disease severity in osteoarthritis (OA) and to ascertain
progression by determining changes in joint space. With
the acknowledged limitations of these methods, develop-
ment of methods to directly visualize and measure joint
tissues including magnetic resonance imaging (MRI) have
been pursued1. Much of this focus has been on measure-
ment of articular cartilage morphometry. Measurement of
morphometry appears to correlate well with the ex vivo as-
sessments of cartilage volume (stripped away from bone),
in addition to possessing adequate precision and sensitivity
to change 2e4. Recent MRI studies, however, have observed
small rates of change (1e3% loss per year) and
standardized response means of 0.3e0.5 per year5e8.
Possibly more importantly these measures of quantitative
cartilage morphometry appear most useful (sensitive to
change) in persons with late stage disease (such as in those
with established JSN or extensive areas of denuded carti-
lage)9. If the pathological changes of cartilage loss are irre-
versible, and we focus especially on those at the end stage
of the disease, we may not be able to accomplish our goal
of modifying the progress of the condition as a drug may
not produce cartilage in an already denuded area.
Thus, despite inherent advantages much of the potential
of MRI to measure structural changes remains to be real-
ized. While quantitative measurement of morphology can
be used to monitor loss of cartilage tissue, there is exten-
sive interest in using MRI to detect changes that precede
gross tissue degradation that may occur in early disease.
Applications of parametric mapping techniques to image
compositional changes that may be sensitive to early carti-
lage damage including T2 mapping, delayed Gadolinium
Enhanced MRI of Cartilage (dGEMRIC) and T1rho have
been extensively reviewed elsewhere10,11. Intuitively, com-
positional measures may have a great role to play in exam-
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557defects are apparent, whereas morphologic measures e
both semi-quantitative and quantitative e may have
a greater role in later stages of disease.
One of the most widely used measures is dGEMRIC,
which relies on intravenous injection of a negatively
charged MR contrast agent and the acquisition of a T1
map after equilibration of the contrast agent in the cartilage,
to estimate the glycosaminoglycan distribution within carti-
lage12. The manuscript in this issue of Osteoarthritis and
Cartilage by Multanen et al13 provides an important ad-
vance in our knowledge of this technique. They examine
the reproducibility of this measure and demonstrate that
the root-mean-square average coefﬁcient of variation
(CVRMS) ranged between 4.7 and 12.9% and the intraclass
correlation coefﬁcient (ICC) ranged between 0.45 and 0.98.
For the major regions of the knee the reproducibility was
good to excellent; the CVRMS and ICC for bulk dGEMRIC
were 4.2% and 0.95 for femur, 5.5% and 0.87 for tibia, and
4.8% and 0.97 for patella. The availability of these perfor-
mance metrics is helpful when establishing the measure-
ment characteristics ( precision, accuracy, validity) of
a speciﬁc marker and are helpful in future study planning.
There are a number of important limitations to his study,
particularly pertaining to generalizing the study ﬁndings,
that remain worthy of further investigation. Most importantly
the population studied does not have OA, and are young
(mean age 32 years) and not obese. It is very likely that if
a population with OA were studied there would be greater
variability and hence less precision and thus the same
study needs to be repeated in a population that reﬂects
something similar to what we would envisage in a clinical
study. For reasons that are unclear ( potentially the authors
were trying to maximize the cartilage thickness being stud-
ied) the measures are made in the lateral tibiofemoral com-
partment whereas disease is much more common medially.
The CVs and ICCs presented in this study do not
compare favorably to other measures including joint space
narrowing, cartilage morphometry and BMD measures on
DEXA. Precision in measurement science can be inﬂu-
enced by biological variability ( for example the inﬂuence
that would be expected for example from diurnal change
in cartilage hydration), technical variability ( for example
what would be expected from differences in knee position
when the scan was acquired) and reproducibility ( for exam-
ple inconsistency introduced in manually processing the
imaging data by observers who may select slightly different
segmented regions). The investigators have tried to limit the
biological variability (by reducing the diurnal variation when
scans were obtained) and the technical variability (by using
well trained and calibrated technicians and a clearly stated
558 D. J. Hunter: One small step in the right direction for MRIprotocol for acquisition). While it is not possible to ascertain
from the results presented what the variability between
measures is from, OA investigators should be encouraged
to do so. For example, one could use this data to ascertain
the measurement reproducibility on the same images by the
same observer and between observers. This knowledge
would be helpful in outlining the one potentially major
source of variability and promoting improvement in the re-
producibility of these measures. If the variability introduced
from technical and measurement differences exceeds that
from pathologic change it will make ascertainment of dis-
ease related change much more demanding.
Thus the current study is but one small step in the direc-
tion towards improved knowledge of the performance
metrics of markers that are useful in OA clinical studies.
Of immediate greatest import for supposedly ‘‘early’’
changes of OA, the natural course of these changes and
the relationship with clinical outcome remains to be estab-
lished. At present there is limited data on the longitudinal
assessment of compositional measures in comparison
with the clinical constructs14. Further assessment of the
psychometrics of MRI measures is greatly needed to facili-
tate further application in clinical trials.Conﬂict of interest
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